Translational issues with the development of cognition enhancing drugs

Arjan Blokland; Nick van Goethem; Pim Heckman; Rudy Schreiber; Jos Prickaerts

doi:10.3389/fneur.2014.00190

Translational issues with the development of cognition enhancing drugs

Front Neurol. 2014 Sep 25:5:190. doi: 10.3389/fneur.2014.00190. eCollection 2014.

Authors

Arjan Blokland¹, Nick van Goethem², Pim Heckman³, Rudy Schreiber⁴, Jos Prickaerts²

Affiliations

¹ Faculty of Psychology and Neuroscience, Department of Neuropsychology and Psychopharmacology, Maastricht University , Maastricht , Netherlands.
² Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University , Maastricht , Netherlands.
³ Faculty of Psychology and Neuroscience, Department of Neuropsychology and Psychopharmacology, Maastricht University , Maastricht , Netherlands ; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University , Maastricht , Netherlands.
⁴ Suadeo Drug Discovery Consulting LLC , Boston, MA , USA.

No abstract available

Keywords: Alzheimer’s disease; animal models; cognition enhancing drugs; drug development; memory; pharmacokinetics; pharmacology; translational medical research.